Free Trial

Dimensional Fund Advisors LP Has $134.87 Million Stock Holdings in Revvity Inc. $RVTY

Revvity logo with Medical background

Key Points

  • Dimensional Fund Advisors LP reduced its stake in Revvity Inc. by 1.6%, now owning approximately 1.08% of the company valued at $134.87 million.
  • Several hedge funds have significantly increased their holdings in Revvity, with EdgePoint Investment Group boosting theirs by 51.1% and GAMMA Investing LLC by an astonishing 15,023.0%.
  • Revvity announced a quarterly dividend of $0.07 per share, yielding an annualized dividend of 0.3%, with the payment date set for November 7th.
  • Looking to export and analyze Revvity data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Dimensional Fund Advisors LP reduced its stake in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 1.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,274,786 shares of the company's stock after selling 20,974 shares during the quarter. Dimensional Fund Advisors LP owned about 1.08% of Revvity worth $134,865,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the business. Kovitz Investment Group Partners LLC increased its stake in Revvity by 41.7% in the first quarter. Kovitz Investment Group Partners LLC now owns 9,464 shares of the company's stock valued at $1,001,000 after purchasing an additional 2,784 shares during the period. Neuberger Berman Group LLC boosted its holdings in Revvity by 10.3% during the first quarter. Neuberger Berman Group LLC now owns 13,846 shares of the company's stock worth $1,465,000 after buying an additional 1,291 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its holdings in shares of Revvity by 6.8% in the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,488 shares of the company's stock valued at $475,000 after purchasing an additional 286 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Revvity by 25.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company's stock valued at $73,000 after purchasing an additional 140 shares in the last quarter. Finally, S Bank Fund Management Ltd acquired a new position in shares of Revvity in the first quarter valued at approximately $435,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on RVTY. Evercore ISI lowered their price target on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. UBS Group raised shares of Revvity from a "neutral" rating to a "buy" rating and decreased their price target for the company from $145.00 to $115.00 in a report on Thursday, May 1st. Stifel Nicolaus decreased their price target on shares of Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a report on Tuesday, July 29th. JPMorgan Chase & Co. decreased their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Finally, Wall Street Zen downgraded shares of Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 3rd. Ten investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $120.07.

Read Our Latest Analysis on RVTY

Revvity Stock Performance

Shares of NYSE RVTY traded down $0.51 during trading hours on Tuesday, hitting $91.63. 504,460 shares of the stock were exchanged, compared to its average volume of 1,171,001. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. The company's 50 day moving average is $94.49 and its 200 day moving average is $98.56. The firm has a market capitalization of $10.64 billion, a P/E ratio of 38.82, a P/E/G ratio of 2.53 and a beta of 0.91. Revvity Inc. has a one year low of $85.12 and a one year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. The firm had revenue of $720.28 million during the quarter, compared to analysts' expectations of $711.26 million. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The business's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.22 EPS. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, research analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity's dividend payout ratio is presently 11.86%.

About Revvity

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

See Also

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines